Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pleural Mesothelioma Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04969315
What this trial is testing

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

Who this might be right for
Renal Cell CancerCastrate Resistant Prostate CancerNon Small Cell Lung Cancer+1 more
Portage Biotech 35
Testing effectiveness (Phase 2)Study completedNCT01291420
What this trial is testing

Dendritic Cell Vaccination for Patients with Solid Tumors

Who this might be right for
GlioblastomaRenal Cell CarcinomaSarcomas+3 more
University Hospital, Antwerp 48
Early research (Phase 1)Ended earlyNCT02372227
What this trial is testing

Dose Escalation Study of VS-5584 Administered in Combination With VS-6063, in Subjects With Relapsed Malignant Mesothelioma

Who this might be right for
Relapsed Malignant Mesothelioma
Verastem, Inc. 21
Large-scale testing (Phase 3)Study completedNCT02349412
What this trial is testing

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers

Who this might be right for
Liver CancerAnxiety DisorderDepression+7 more
Alliance for Clinical Trials in Oncology 405
Testing effectiveness (Phase 2)Study completedNCT01085630
What this trial is testing

Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 72
Not applicableLooking for participantsNCT07126509
What this trial is testing

Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma

Who this might be right for
MesotheliomaMesothelioma; LungMesotheliomas Pleural+2 more
University of Chicago 30
Testing effectiveness (Phase 2)UnknownNCT04713761
What this trial is testing

Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Shanghai Pulmonary Hospital, Shanghai, China 15
Not applicableActive Not RecruitingNCT03269227
What this trial is testing

Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 30
Testing effectiveness (Phase 2)Study completedNCT00004183
What this trial is testing

Capecitabine in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 27
Early research (Phase 1)Study completedNCT05538572
What this trial is testing

PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
Breast CancerGlioblastomaHead and Neck Squamous Cell Carcinoma+4 more
Prelude Therapeutics Incorporated 22
Testing effectiveness (Phase 2)UnknownNCT02879669
What this trial is testing

A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming GM-CSF Coding Oncolytic Adenovirus, and Pemetrexed/Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma

Who this might be right for
To Determine Safety, Tolerability and Efficacy of ONCOS-102 in Combination With Chemotherapy
Targovax Oy 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT03126630
What this trial is testing

Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma

Who this might be right for
Pleural Malignant Mesothelioma
National Cancer Institute (NCI) 49
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Testing effectiveness (Phase 2)Study completedNCT00334594
What this trial is testing

Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Swiss Cancer Institute 153
Early research (Phase 1)Study completedNCT00020124
What this trial is testing

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Ended earlyNCT00165503
What this trial is testing

Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate

Who this might be right for
Pleural MesotheliomaMalignant Pleural Mesothelioma
Dana-Farber Cancer Institute 16
Early research (Phase 1)Looking for participantsNCT03760575
What this trial is testing

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesotheliomas Pleural
Abramson Cancer Center at Penn Medicine 20
Large-scale testing (Phase 3)Study completedNCT02709512
What this trial is testing

Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

Who this might be right for
Mesothelioma
Polaris Group 249
Testing effectiveness (Phase 2)Ended earlyNCT03502746
What this trial is testing

Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma

Who this might be right for
Mesothelioma, Malignant
Arkadiusz Z. Dudek, MD 34
Early research (Phase 1)Study completedNCT06469138
What this trial is testing

Investigate 14C-bemcentinib in Healthy Male Subjects

Who this might be right for
Non-Small Cell Lung CancerMetastatic MelanomaAcute Myeloid Leukemia+5 more
BerGenBio ASA 6
Next Page